Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (201-210 of 401) with videos related to

Pageof 41
Sort By:
Journal of the American Heart Association|December 24, 2022
Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO TrialMarcus Hjort, Kai M Eggers, Tatevik Ghukasyan Lakic, et al.
The Canadian Journal of Cardiology|March 19, 2026
Practice Patterns in Antiplatelet Management of Patients with Acute Coronary Syndromes Treated Medically Without Revascularization: a Multi-Center SurveyKevin Haddad, Kevin Bainey, Jay Shavadia, et al.
Circulation|May 14, 2014
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial"P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Cardiovascular Research|March 4, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular diseasePia Davidsson, Susanna Eketjäll, Niclas Eriksson, et al.
BMJ (Clinical Research Ed.)|June 21, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trialStefan K James, Matthew T Roe, Christopher P Cannon, et al.
Circulation|January 2, 2013
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyPayal Kohli, Lars Wallentin, Eric Reyes, et al.
American Heart Journal|June 2, 2015
Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trialMatthijs A Velders, Lars Wallentin, Richard C Becker, et al.
Journal of the American College of Cardiology|July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 TrialElizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.
Thrombosis and Haemostasis|November 22, 2014
Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?Dániel Aradi, Jean-Philippe Collet, Johannes Mair, et al.
Pageof 41

Showing results (201-210 of 401) with videos related to

Sort By:
Pageof 41
Journal of the American Heart Association|December 24, 2022
Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO TrialMarcus Hjort, Kai M Eggers, Tatevik Ghukasyan Lakic, et al.
The Canadian Journal of Cardiology|March 19, 2026
Practice Patterns in Antiplatelet Management of Patients with Acute Coronary Syndromes Treated Medically Without Revascularization: a Multi-Center SurveyKevin Haddad, Kevin Bainey, Jay Shavadia, et al.
Circulation|May 14, 2014
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial"P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Cardiovascular Research|March 4, 2023
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular diseasePia Davidsson, Susanna Eketjäll, Niclas Eriksson, et al.
BMJ (Clinical Research Ed.)|June 21, 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trialStefan K James, Matthew T Roe, Christopher P Cannon, et al.
Circulation|January 2, 2013
Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyPayal Kohli, Lars Wallentin, Eric Reyes, et al.
American Heart Journal|June 2, 2015
Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trialMatthijs A Velders, Lars Wallentin, Richard C Becker, et al.
Journal of the American College of Cardiology|July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 TrialElizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
European Heart Journal|April 15, 2014
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trialDaniel Lindholm, Christoph Varenhorst, Christopher P Cannon, et al.
Thrombosis and Haemostasis|November 22, 2014
Platelet function testing in acute cardiac care - is there a role for prediction or prevention of stent thrombosis and bleeding?Dániel Aradi, Jean-Philippe Collet, Johannes Mair, et al.
Pageof 41